US OptionsDetailed Quotes
HIMS241011C22000
- 0.05
- -0.10-66.67%
15min DelayTrading Oct 7 10:53 ET
0.15High0.05Low
0.08Open0.15Pre Close528 Volume14 Open Interest22.00Strike Price6.36KTurnover83.16%IV15.14%PremiumOct 11, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.0954Delta0.0976Gamma255.33Leverage Ratio-0.0331Theta0.0002Rho24.37Eff Leverage0.0035Vega
Hims & Hers Health Stock Discussion
Sign in to post a comment
Good morning, traders. Happy Monday, October 7th, the air was dark and chilly in Jersey City, and the market was falling but individual stocks were flying on the news. Last week was a volatile one, this week will see updated CPI inflation numbers and the start of the Q3 earnings season.
My name is Kevin Travers; here are stonks and stories you have to know about on Wall Street today.
$Hims & Hers Health (HIMS.US)$ shares are trading 9...
My name is Kevin Travers; here are stonks and stories you have to know about on Wall Street today.
$Hims & Hers Health (HIMS.US)$ shares are trading 9...
7
4
Morning Movers
Gapping up
$Pfizer (PFE.US)$ stock increased by 3.4% following a Bloomberg report that activist investor Starboard Value acquired approximately $1 billion in shares of the pharmaceutical giant, aiming to drive a turnaround for the company.
$Hims & Hers Health (HIMS.US)$ saw its stock rise by 5.4% after it was announced that the telehealth company would be joining the S&P SmallCap 600, replacing Vector Group, the...
Gapping up
$Pfizer (PFE.US)$ stock increased by 3.4% following a Bloomberg report that activist investor Starboard Value acquired approximately $1 billion in shares of the pharmaceutical giant, aiming to drive a turnaround for the company.
$Hims & Hers Health (HIMS.US)$ saw its stock rise by 5.4% after it was announced that the telehealth company would be joining the S&P SmallCap 600, replacing Vector Group, the...
40
1
$Hims & Hers Health (HIMS.US)$ guess what is the price by end of this week?
$Hims & Hers Health (HIMS.US)$ If you didn’t hop in yesterday, you’re missing out on some profits tbh. Yesterday was a solid entry point. Target’s still set at 20.5, with a good entry around 17.3 - .5
$Hims & Hers Health (HIMS.US)$
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
Their obesity drug is not affected by the side effects discovered by Novo Nordisk.
Novo's drug is CB1 receptor based
HIMS' is manufactured by Nivagen and is a GLP-1 injection.
1
Morning Movers
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
Gapping up
$NVIDIA (NVDA.US)$ shares were set to rise on Thursday as investors processed the news of the chipmaker's investment in ChatGPT creator, OpenAI. Shares rose 1.4% in premarket.
$Wolfspeed (WOLF.US)$, a silicon carbide technology company, was downgraded by Mizuho from Neutral to Underperform, with the price target lowered from $17 to $8. The stock dropped 5.25% to $8.67.
Gapping down
$Tesla (TSLA.US)$ dropp...
30
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
No comment yet
104476495 : h
152236641 104476495 : I am watching MSTR, PLTR, NVDA, XOM, MU, SQ, BA, XPEV, GLD, SLV
Joyce Johnson : Thanks for the update
Kevin Travers OP 152236641 : Nice!! I’ll check these out!!